SURMODICS-MODIFIED PRODUCT AGREEMENTModified Product Agreement • May 4th, 2007 • Devax Inc • Minnesota
WHEREAS, SURMODICS and DEVAX are parties to a Master License Agreement, dated March 21, 2003, which Master License Agreement contains an Attachment B1 dated March 21, 2003 that describes a Medical Product, a component part of which is to be modified by SURMODICS under this Agreement through the application by SURMODICS of the coating technology licensed to DEVAX under the Master License Agreement.
SURMODICS-MODIFIED PRODUCT AGREEMENTModified Product Agreement • April 5th, 2005 • Ev3 Inc. • Minnesota
WHEREAS, SURMODICS has developed proprietary processes and products involving the use of chemical compositions that incorporate latent reactive chemical groups for bonding molecules, synthetic polymers and other chemical species onto surfaces, into matrices, and to other molecules ("SURMODICS' Technology"); and
ATTACHMENT A3 February 21,2002 SurModics-Modified Product Agreement between SurModics, Inc. and ev3 Inc., successor in interest to Microvena CorporationModified Product Agreement • April 5th, 2005 • Ev3 Inc.
